Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the NAB2-STAT6 fusion gene. Issue 6 (31st October 2016)
- Record Type:
- Journal Article
- Title:
- Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the NAB2-STAT6 fusion gene. Issue 6 (31st October 2016)
- Main Title:
- Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the NAB2-STAT6 fusion gene
- Authors:
- Kouba, Erik
Simper, Novae B
Chen, Shaoxiong
Williamson, Sean R
Grignon, David J
Eble, John N
MacLennan, Gregory T
Montironi, Rodolfo
Lopez-Beltran, Antonio
Osunkoya, Adeboye O
Zhang, Shaobo
Wang, Mingsheng
Wang, Lisha
Tran, Thu
Emerson, Robert E
Baldrige, Lee Ann
Monn, M Francesca
Linos, Konstantinos
Cheng, Liang - Abstract:
- Abstract : Aims: To characterise clinicopathological features and clinical outcomes of the genitourinary tract solitary fibrous tumours, incorporating NAB2 - STAT6 gene fusion status. Methods: The presence of the molecular hallmark NAB2 - STAT6 gene fusion and for the defining fusion partner product STAT6 was assessed in 11 cases of the genitourinary tract solitary fibrous tumours. NAB2 - STAT6 gene fusion analysis was performed using a break-apart fluorescence in situ hybridisation (FISH) probe using a probe cocktail with Bacterial artificial chromosome (BAC) clones for STAT6 and NAB2 . Results: Eleven solitary fibrous tumours were diagnosed in eight male patients and three female patients with a mean age of 46 years (range: 11–64 years). Four of the tumours had malignant histological features, and three were considered moderate risk for metastasis. With a mean follow-up time of 61 months, 1 recurred locally and 2 presented at distant metastatic sites. Using a break-apart FISH probe cocktail, we found the NAB2 - STAT6 gene fusion and nuclear STAT6 expression in 58% and 91% of cases, respectively. However, the NAB2 - STAT6 fusion status was not correlated with STAT6 expression or useful in discriminating between malignant histological features or subsequent clinical outcomes in the genitourinary solitary fibrous tumours. Conclusions: A subset of solitary fibrous tumours of the genitourinary tract behaved aggressively. Using a break-apart FISH probe cocktail, we found theAbstract : Aims: To characterise clinicopathological features and clinical outcomes of the genitourinary tract solitary fibrous tumours, incorporating NAB2 - STAT6 gene fusion status. Methods: The presence of the molecular hallmark NAB2 - STAT6 gene fusion and for the defining fusion partner product STAT6 was assessed in 11 cases of the genitourinary tract solitary fibrous tumours. NAB2 - STAT6 gene fusion analysis was performed using a break-apart fluorescence in situ hybridisation (FISH) probe using a probe cocktail with Bacterial artificial chromosome (BAC) clones for STAT6 and NAB2 . Results: Eleven solitary fibrous tumours were diagnosed in eight male patients and three female patients with a mean age of 46 years (range: 11–64 years). Four of the tumours had malignant histological features, and three were considered moderate risk for metastasis. With a mean follow-up time of 61 months, 1 recurred locally and 2 presented at distant metastatic sites. Using a break-apart FISH probe cocktail, we found the NAB2 - STAT6 gene fusion and nuclear STAT6 expression in 58% and 91% of cases, respectively. However, the NAB2 - STAT6 fusion status was not correlated with STAT6 expression or useful in discriminating between malignant histological features or subsequent clinical outcomes in the genitourinary solitary fibrous tumours. Conclusions: A subset of solitary fibrous tumours of the genitourinary tract behaved aggressively. Using a break-apart FISH probe cocktail, we found the NAB2 - STAT6 gene fusion in 64% of cases. However, the NAB2 - STAT6 fusion status was not correlated with STAT6 expression or useful in discriminating between low-risk or high-risk tumours and subsequent clinical outcomes. … (more)
- Is Part Of:
- Journal of clinical pathology. Volume 70:Issue 6(2017)
- Journal:
- Journal of clinical pathology
- Issue:
- Volume 70:Issue 6(2017)
- Issue Display:
- Volume 70, Issue 6 (2017)
- Year:
- 2017
- Volume:
- 70
- Issue:
- 6
- Issue Sort Value:
- 2017-0070-0006-0000
- Page Start:
- 508
- Page End:
- 514
- Publication Date:
- 2016-10-31
- Subjects:
- KIDNEY -- CYTOGENETICS -- IN SITU HYBRIDISATION -- GENITOURINARY PATHOLOGY
Pathology -- Periodicals
Pathology, Molecular -- Periodicals
616.0705 - Journal URLs:
- http://jcp.bmjjournals.com ↗
http://jcp.bmjjournals.com/content/by/year ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=162&action=archive ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/jclinpath-2016-204088 ↗
- Languages:
- English
- ISSNs:
- 0021-9746
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19478.xml